The moment Julian’s footsteps faded down the hall, Grant opened his eyes.
“Don’t… tell him… anything,” Grant whispered.
I nodded solemnly.
At four o’clock sharp, Dr. Ruben Barragan arrived carrying a worn leather medical bag. He pulled out an unlabeled white box with a single name handwritten on the side. He drew a clear liquid into a syringe and injected it directly into Grant’s IV line.
Ten minutes later, the rhythm of Grant’s breathing faltered. His fingers went entirely limp.
“He’s slipping away,” Dr. Barragan remarked with terrifying calm. “Five days. Maybe six.”
Instead of leaving the ampoules with the rest of Grant’s prescribed medication, Barragan slipped them back into his personal bag.
Late that night, while the house slept, I looked up the drug name I had memorized from the box.
I read the medical description once. Then twice.
The drug was a heavy paralytic agent. Administered in unmonitored doses, it induced profound muscle immobility and suppressed breathing—simulating the final stages of a terminal neurodegenerative collapse.